GEODE CAPITAL MANAGEMENT, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 63 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$16,810,603
-59.5%
1,793,864
+6.1%
0.00%
-60.0%
Q2 2023$41,474,775
+16.8%
1,690,777
+10.8%
0.01%0.0%
Q1 2023$35,496,493
+95549.5%
1,525,418
+4.0%
0.01%0.0%
Q4 2022$37,111
-99.9%
1,466,278
+3.5%
0.01%
+25.0%
Q3 2022$27,304,000
-22.3%
1,416,229
+2.7%
0.00%
-20.0%
Q2 2022$35,119,000
+9.6%
1,378,869
+10.7%
0.01%
+25.0%
Q1 2022$32,031,000
-37.9%
1,245,391
+1.1%
0.00%
-33.3%
Q4 2021$51,576,000
-0.9%
1,231,820
+3.0%
0.01%
-14.3%
Q3 2021$52,039,000
-5.7%
1,195,758
+2.4%
0.01%
-12.5%
Q2 2021$55,191,000
-0.1%
1,167,340
+8.3%
0.01%0.0%
Q1 2021$55,239,000
+113.5%
1,077,422
+11.5%
0.01%
+100.0%
Q4 2020$25,879,000
-17.6%
966,375
+5.7%
0.00%
-33.3%
Q3 2020$31,388,000
+96.7%
914,310
+134.8%
0.01%
+100.0%
Q2 2020$15,954,000
+300.5%
389,423
+234.9%
0.00%
+200.0%
Q1 2020$3,984,000
+349.7%
116,280
+64.8%
0.00%
Q4 2019$886,00070,5580.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$40,100,00021.56%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$571,412,0002.71%
Nan Fung Group Holdings Ltd 210,563$5,416,0002.57%
Taikang Asset Management (Hong Kong) Co Ltd 533,332$13,717,0002.34%
Crawford Lake Capital Management, LLC 168,200$4,326,0001.80%
BOULDER HILL CAPITAL MANAGEMENT LP 126,900$3,264,0001.75%
Zebra Capital Management LLC 22,227$572,0001.31%
Alaska Permanent Fund Corp 2,300,000$59,156,0000.98%
CLARK ESTATES INC/NY 180,000$4,630,0000.73%
Temasek Holdings (Private) Ltd 5,602,553$144,097,6630.61%
View complete list of VIR BIOTECHNOLOGY INC shareholders